Ortin Global Ltd. engages in the manufacture of drug intermediates and pharmaceuticals products. It focuses on the formulations, active pharmaceutical ingredient (API) intermediates, research and development, bio-technology, and merchant export trading. Its product portfolio includes tablets, capsules, syrups, and dry powders. The company was founded on October 27, 1986 and is headquartered in Hyderabad, India.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company